Home > Cashflow Statement > NEULAND LABORATORIES

NEULAND LABORATORIES
Cash Flow from Financing Activities

    Back to Cashflow Statement
NEULAND LABORATORIES is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
Best 1M Momentum Small Cap Stocks
COMMUNITY POLL
for NEULAND LABORATORIES
Please provide your vote to see the results

NEULAND LABORATORIES Last 5 Year Cash Flow from Financing Activities History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
Cash Flow from Financing Activities ₹25 Cr₹-69 Cr₹-136 Cr₹38 Cr₹-114 Cr

What is the latest Cash Flow from Financing Activities ratio of NEULAND LABORATORIES ?

The latest Cash Flow from Financing Activities ratio of NEULAND LABORATORIES is ₹25 Cr based on Mar2025 Consolidated results.
Year Cash Flow from Financing Activities
Mar2025₹25 Cr
Mar2024₹-69 Cr
Mar2023₹-136 Cr
Mar2022₹38 Cr
Mar2021₹-114 Cr

How is Cash Flow from Financing Activities of NEULAND LABORATORIES Trending?

Years Cash Flow from Financing Activities % Change
Mar2025 ₹25 Cr
Positive
Mar2024 ₹-69 Cr
Negative
Mar2023 ₹-136 Cr
Negative
Mar2022 ₹38 Cr
Positive
Mar2021 ₹-114 Cr -

Compare Cash Flow from Financing Activities of peers of NEULAND LABORATORIES

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
NEULAND LABORATORIES ₹18,232.3 Cr -2.5% 16.4% 70.8% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹406,267.0 Cr 0.7% 2.8% 7.9% Stock Analytics
DIVIS LABORATORIES ₹178,672.0 Cr -0.8% 3.7% 48.6% Stock Analytics
CIPLA ₹119,713.0 Cr -0.2% -0.1% -1.9% Stock Analytics
TORRENT PHARMACEUTICALS ₹119,195.0 Cr 3.4% 11.2% 17.9% Stock Analytics
DR REDDYS LABORATORIES ₹104,999.0 Cr 0.6% -5.2% -4.9% Stock Analytics


NEULAND LABORATORIES Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
NEULAND LABORATORIES

-2.5%

16.4%

70.8%

SENSEX

-0.9%

0.4%

1.4%


You may also like the below Video Courses